LED phototherapy brand strengthens Irish support
Dermalux has reinforced its commitment to the Irish market with the appointment of Rachel Hand as business manager for Ireland, responding to growing demand for non-invasive, device-led aesthetic treatments.
Having worked across Ireland for the past five years with medical grade skincare brands, Rachel Hand says clinics are seeing a clear change in client priorities. She comments:
“People are really moving away from invasive treatments that require downtime, but they are still looking for results driven treatments. It is not just about the aesthetic results. It is also about cellular health and how we can help those cells function more effectively now, and in the future.”
She adds:
“People may have had an experience where they bought something online and it never did anything for them. My job is to make sure they understand why that was, and why Dermalux is different.”
The Dermalux Tri Wave MD is CE marked as a Class IIa medical device for dermatological and musculoskeletal conditions, wound healing and pain management, FDA cleared for the temporary relief of muscle and joint pain, arthritis and stiffness. It delivers blue light at 415nm, red light at 633nm and near infrared at 830nm.
Dermalux Academy
